Any positives?, page-97

First 97 Last

Share
Profile

Follow
dontaskme

3,401 Posts.

72

11/03/22

13:24

Post #: 60138507
Share

Originally posted by Greg7270: ↑

I agree with your post Slippin. The science hasn't changed only the timelines.

The TGA and EU Common List requirements are changing monthly and becoming more stringent. The company has been caught up in the revised changes and has had to quickly organise clinical trials. Everyone seemed to expect these trials to be completed quickly but in reality they take around 6 months to complete and submit. The Company has never said how long these trials will take in any announcements.

The problems with RAT testing started to surface around December 2021 and with the new Omicron Strain, WHO and MDCG developed new guidelines for regulatory approval. So many companies have now had their regulation rejected because they haven't provided clinical data. This was included in the slides yesterday.

*TGA post market surveillance currently being conducted by
Doherty Institute, with the current focus on variants of
concern. Stringent post market surveillance is expected in the
future.
• EU Common List is updated monthly – it has removed 10 test
and ~180 test rejected for not meeting MDCG guidelines.1
• Independent evaluations undertaken by the German Paul
Ehrlich Institute have found that, out of 245 tests analysed 46
did not meet the criteria. 2

Unfortunately, Derek presented the information poorly yesterday and focused on the reasons for delays. Some of which were out of his control and not providing enough detail in previous announcements. Even if he tried to spin this differently he would have been found out.

It was the emphasis on delays and possible uncertainty with TGA and EU Common List approval that caused panic in the market.

The Company is confident they have a quality product and have ISO accreditation to prove it.

The current market price is below the 52 week low and one needs to assess whether the company has gone backwards that far. I don't think so.

COVID is so dynamic and we are going to see more changes and problems in the future. Because there are so many RAT tests picking up false negatives and positives, I would not be surprised to see them removed from point of sale and back to relying only on PCR testing.

The medical profession will only want accurate and proven technology. I still have confidence in our science and technology that it will compete with PCR testing.

The share price is creating a good opportunity for a hostile take over.

Expand

If someone wanted to take it over it was well lower than this for a very long time.

ADO Price at posting: 9.4¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell wins first international approval for nerve repair product

DRO

Droneshield shares move up on $13.5M US govt contract

LMS

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

TMK

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

WAF

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

There are more pages in this discussion • 220 more messages in this thread...

First 97 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change -0.001(4.55%)		Mkt cap ! $52.28M

Open	High	Low	Value	Volume
2.1¢	2.1¢	2.1¢	$28.14K	1.340M

Buyers (Bids)

No.	Vol.	Price($)
4	579636	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	628168	6

View Market Depth

No.	Vol.	Price($)
4	579636	0.021
12	1688457	0.020
9	2105131	0.019
6	2157002	0.018
5	1724748	0.017

Price($)	Vol.	No.
0.022	628168	6
0.023	542868	8
0.024	141966	2
0.025	478846	7
0.026	38461	1

Last trade - 15.24pm 08/10/2024 (20 minute delay)

ADO (ASX) Chart

Any positives?, page-97

Orthocell wins first international approval for nerve repair product

Droneshield shares move up on $13.5M US govt contract

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Any positives?, page-97

Top Stories

Orthocell wins first international approval for nerve repair product

Droneshield shares move up on $13.5M US govt contract

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News